Ruxolitinib Response in Teens, Adults With Vitiligo Compared ...Middle East

Medscape - News
Pooled data from the phase 3 TRuE-V1 and TRuE-V2 studies were used to evaluate responses in a subset of adolescents treated with the topical JAK inhibitor for vitiligo. Medscape Medical News

Hence then, the article about ruxolitinib response in teens adults with vitiligo compared was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ruxolitinib Response in Teens, Adults With Vitiligo Compared )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News